FDA grants accelerated approval for Astellas, Seattle Genetics' bladder cancer drug

U.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma Inc and Seattle Genetics' experimental drug to treat advanced bladder cancer, about three months ahead of schedule.

from Reuters: U.S. https://ift.tt/2ZaabX6